Skip to search formSkip to main contentSkip to account menu

Memantine

Known as: 1-Amino-3,5-dimethyladamantane, 3,5-Dimethyl-1-adamantanamine, 3,5-Dimethyl-1-aminoadamantane 
AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
El tratamiento sintomatico de la enfermedad de Alzheimer se realiza en la actualidad a traves de una doble aproximacion… 
2010
2010
The authors tested visual-evoked potentials to pattern-reversal, motion-onset, and visual cognitive event-related potentials in… 
Review
2008
Review
2008
ZusammenfassungDemente Patienten im höheren Lebensalter leiden vorwiegend unter gemischten Demenzen, wobei die… 
2006
2006
Purpose. We report the ocular motor and visual acuity effects of the first use of the tenotomy procedure on different types of… 
2006
2006
Objetivos. Revisar las publicaciones sobre eficacia de la memantina en la alteracion cognitiva, y comentar datos procedentes de… 
2004
2004
Symptoms of acute poisoning with nerve agents such as organophosphorus (OP) compounds include general convulsions that could lead… 
2000
2000
At present, the treatment options for Alzheimer's disease are largely symptomatic giving rise to temporary remissions in… 
1983
1983
1,3-Dimethyl-5- aminoadamantine ( DMAA , D-145, memantine ( Memantine ) has anticonvulsant properties and potentiates the actions… 
1982
1982
: The effect of 1,3-dimethyl-5-aminoadamantane (DMAA, D-145, memantine, Memantine) in the concentration range of 10(-6) to 10(-3… 
Review
1982
Review
1982
In the present review the effects of 1,3-dimethyl-5-amino-adamantane (DMAA, D-145, Memantine, Memantine) on various…